Clinical Outcomes After 1 Year of Augmented Insulin Pump Therapy in Patients with Diabetes in a Specialized Diabetes Center in Medellín, Colombia
| العنوان: | Clinical Outcomes After 1 Year of Augmented Insulin Pump Therapy in Patients with Diabetes in a Specialized Diabetes Center in Medellín, Colombia |
|---|---|
| المؤلفون: | HincapieGloria, TorresJose Luis, ArangoClaudia Monsalve, AbadVeronica, Ramirez-RinconAlex, DelgadoMaria, AristizabalNatalia, CastilloEstefany, PalacioAndres, CuestaDiana Paola, ZapataEliana, Hincapie-GarcíaJaime, BoteroJosé Fernando |
| المصدر: | Diabetes Technology & Therapeutics. 18:713-718 |
| بيانات النشر: | Mary Ann Liebert Inc, 2016. |
| سنة النشر: | 2016 |
| مصطلحات موضوعية: | Adult, Blood Glucose, Male, Insulin pump, medicine.medical_specialty, Pediatrics, Adolescent, Diabetic ketoacidosis, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Type 2 diabetes, Colombia, Hypoglycemia, Young Adult, 03 medical and health sciences, Insulin Infusion Systems, 0302 clinical medicine, Endocrinology, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Insulin, 030212 general & internal medicine, Child, Aged, Retrospective Studies, Type 1 diabetes, business.industry, Retrospective cohort study, Middle Aged, medicine.disease, Surgery, Medical Laboratory Technology, Diabetes Mellitus, Type 1, Treatment Outcome, Diabetes Mellitus, Type 2, Female, Observational study, business |
| الوصف: | Type 1 diabetes can be difficult to control. Augmented pump therapy (CSII-rtCGM) has become an important tool for controlling blood glucose and decreasing hypoglycemia.Describe the results 1 year after starting CSII-rtCGM in patients with diabetes in Medellín, Colombia. This is an observational, retrospective study. Patients with type 1 and type 2 diabetes started on CSII-rtCGM between January 2008 and June 2015 were included. Qualitative variables were analyzed as absolute or relative frequencies. Quantitative variables were obtained through central tendency and dispersion according to the normal distribution of the analyzed variable using Kolmogorov-Smirnov. SPSS 19 from IBM was used.Two hundred forty-seven patients were identified, of those 183 were included. The starting HbA1C was 8.7% ± 1.7% and 7.4% ± 0.8% (P 0.05) 1 year later. 16.5% of patients had been admitted to the hospital before starting CSII-rtCGM, after 1 year the admission rate was 6.0% (P 0.05). The incidence of severe hypoglycemia at the beginning was 32%, 1 year later it was 7.1%.CSII-rtCGM therapy improves glucose control and decreases severe hypoglycemic events and hospital admission rate. |
| تدمد: | 1557-8593 1520-9156 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69e79f6cd90e6ea9a432432594b499aeTest https://doi.org/10.1089/dia.2016.0166Test |
| حقوق: | CLOSED |
| رقم الانضمام: | edsair.doi.dedup.....69e79f6cd90e6ea9a432432594b499ae |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15578593 15209156 |
|---|